PMC:7558914 / 10970-11242 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"241","span":{"begin":241,"end":249},"obj":"Species"},{"id":"255","span":{"begin":26,"end":44},"obj":"Chemical"},{"id":"256","span":{"begin":49,"end":68},"obj":"Chemical"},{"id":"257","span":{"begin":107,"end":125},"obj":"Chemical"},{"id":"258","span":{"begin":141,"end":153},"obj":"Chemical"},{"id":"259","span":{"begin":158,"end":177},"obj":"Chemical"},{"id":"263","span":{"begin":262,"end":271},"obj":"Disease"}],"attributes":[{"id":"A241","pred":"tao:has_database_id","subj":"241","obj":"Tax:9606"},{"id":"A255","pred":"tao:has_database_id","subj":"255","obj":"MESH:D006886"},{"id":"A256","pred":"tao:has_database_id","subj":"256","obj":"MESH:C558899"},{"id":"A257","pred":"tao:has_database_id","subj":"257","obj":"MESH:D006886"},{"id":"A258","pred":"tao:has_database_id","subj":"258","obj":"MESH:D017963"},{"id":"A259","pred":"tao:has_database_id","subj":"259","obj":"MESH:C558899"},{"id":"A263","pred":"tao:has_database_id","subj":"263","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Different combinations of hydroxychloroquine and lopinavir/ritonavir (7/15, 46.7%) and triple therapy with hydroxychloroquine regimen 3, and azithromycin and lopinavir/ritonavir regimen 2 (6/15, 40%) were the most recommended treatments for patients with severe pneumonia."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T20","span":{"begin":262,"end":271},"obj":"Phenotype"}],"attributes":[{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Different combinations of hydroxychloroquine and lopinavir/ritonavir (7/15, 46.7%) and triple therapy with hydroxychloroquine regimen 3, and azithromycin and lopinavir/ritonavir regimen 2 (6/15, 40%) were the most recommended treatments for patients with severe pneumonia."}

{"project":"LitCovid-sentences","denotations":[{"id":"T71","span":{"begin":0,"end":272},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Different combinations of hydroxychloroquine and lopinavir/ritonavir (7/15, 46.7%) and triple therapy with hydroxychloroquine regimen 3, and azithromycin and lopinavir/ritonavir regimen 2 (6/15, 40%) were the most recommended treatments for patients with severe pneumonia."}